BRADEN R. KELLY - Corporate Board Profile

FAIR ISAAC CORP

Filing Date	Source Excerpt
2014-01-07	Braden R. Kelly. Director since February 2013; Member of the Compensation Committee; Age 43. ... The table below summarizes the compensation paid by the Company to each non-employee director for the year ended September 30, 2013. Braden R. Kelly: Total $448,650.
2015-01-20	Braden R. Kelly. Director since February 2013; Member of the Leadership Development and Compensation Committee; Age 44. ... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors. ... The table below summarizes the compensation paid by the Company to each non-employee director for the year ended September 30, 2014. ... Braden R. Kelly 90,000 fees earned or paid in cash, 102,812 stock awards, 106,215 option awards, total 299,027.
2016-01-20	Braden R. Kelly. Director since 2013; Chair of the Leadership Development and Compensation Committee; Member of the Governance, Nominating and Executive Committee; Age 45. ... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors. ... The table below summarizes the compensation paid by the Company to each non-employee director for the year ended September 30, 2015. ... Braden R. Kelly 85,000 fees earned or paid in cash, 275,414 option awards, total 360,414.
2017-01-11	Braden R. Kelly. Director since 2013 and Chairman of the Board of Directors since February 2016; Chair of the Governance, Nominating and Executive Committee; Member of the Leadership Development and Compensation Committee; Age 46. Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. Mr. Kelly's extensive analysis of the technology and health care industries through his work as a private equity investor provides him with valuable insight into the business environments in which our Company and the companies in some of our key markets operate. The Board also benefits from Mr. Kelly's significant experience as a strategic advisor to companies and his global experience working with growth companies in the United States, Europe and India.
2018-01-26	Braden R. Kelly. Director since 2013 and Chairman of the Board of Directors since February 2016; Chair of the Governance, Nominating and Executive Committee; Member of the Leadership Development and Compensation Committee; Age 47. Mr. Kelly has been a Partner at Health Evolution Partners, a private equity investment firm focused on the health care industry, since January 2015 and has served in various positions at Health Evolution Partners, including Investment Partner from June 2013 to December 2014 and Senior Advisor from August 2008 to May 2013. From August 1995 to December 2006, Mr. Kelly was an employee and then Partner and Managing Director at General Atlantic Partners LLC, a global private equity investment firm focused on technology growth investing. Prior to joining General Atlantic Partners, Mr. Kelly worked in the investment banking division of Morgan Stanley & Co. as a member of the mergers, acquisitions and restructuring department. Mr. Kelly does not serve on any other public board nor has he served on any other public boards in the past five years. Mr. Kelly earned an undergraduate degree from the University of Notre Dame. Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. Mr. Kelly’s extensive analysis of the technology and health care industries through his work as a private equity investor provides him with valuable insight into the business environments in which our Company and the companies in some of our key markets operate. The Board also benefits from Mr. Kelly’s significant experience as a strategic advisor to companies and his global experience working with growth companies in the United States, Europe and India.
2019-01-28	Mr. Kelly has been a Partner at Health Evolution Partners... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors... Mr. Kelly's extensive analysis of the technology and health care industries through his work as a private equity investor provides him with valuable insight into the business environments in which our Company and the companies in some of our key markets operate... The Board also benefits from Mr. Kelly's significant experience as a strategic advisor to companies and his global experience working with growth companies in the United States, Europe and India.
2020-01-28	Mr. Kelly has been a Partner at Health Evolution Partners, a private equity investment firm focused on the health care industry, since January 2015 and has served in various positions at Health Evolution Partners, including Investment Partner from June 2013 to December 2014 and Senior Advisor from August 2008 to May 2013. From August 1995 to December 2006, Mr. Kelly was an employee and then Partner and Managing Director at General Atlantic Partners LLC, a global private equity investment firm focused on technology growth investing. Prior to joining General Atlantic Partners, Mr. Kelly worked in the investment banking division of Morgan Stanley & Co. as a member of the mergers, acquisitions and restructuring department. Mr. Kelly does not serve on any other public company boards nor has he served on any other public company boards in the past five years. Mr. Kelly earned an undergraduate degree from the University of Notre Dame. Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. Mr. Kelly's extensive analysis of the technology and health care industries through his work as a private equity investor provides him with valuable insight into the business environments in which our Company and the companies in some of our key markets operate. The Board also benefits from Mr. Kelly's significant experience as a strategic advisor to companies and his global experience working with growth companies in the United States, Europe and India. Mr. Kelly's Fees Earned or Paid in Cash represent the $162,500 annual board and committee retainers, annual independent chairman of the board retainer and committee chair retainers for the Governance, Nominating and Executive Committee paid quarterly upon his re-election of which $105,000 was foregone by Mr. Kelly to instead receive 1,457 stock options. The amount recognized for financial statement reporting purposes in fiscal 2019 with respect to such options, which was $115,103, is excluded from the Option Awards column. Total compensation was $445,758.
2021-01-27	Braden R. Kelly. Director since 2013 and Chairman of the Board of Directors since February 2016; Chair of the Governance, Nominating and Executive Committee; Member of the Leadership Development and Compensation Committee; Age 50. ... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. ... Mr. Kelly does not serve on any other public company boards nor has he served on any other public company boards in the past five years. ... The table below summarizes the compensation paid by the Company to each non-employee director for the fiscal year ended September 30, 2020. ... Braden R. Kelly 257,500 245,906 — — — — — 503,406
2022-01-25	Braden R. Kelly. Director since 2013 and Chairman of the Board of Directors since February 2016; Chair of the Governance, Nominating and Executive Committee; Member of the Leadership Development and Compensation Committee; Age 51. ... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. ... The table below summarizes the compensation paid by the Company to each non-employee director for the fiscal year ended September 30, 2021. ... Braden R. Kelly 200,000 fees earned or paid in cash, 249,411 stock awards, total 449,411.
2023-01-25	Braden R. Kelly. Director since 2013 and Chairman of the Board of Directors since February 2016; Chair of the Governance, Nominating and Executive Committee; Member of the Leadership Development and Compensation Committee; Age 52. ... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. ... The table below summarizes the compensation paid by the Company to each non-employee director for the fiscal year ended September 30, 2022. Braden R. Kelly 200,000 Fees Earned or Paid in Cash, 255,322 Stock Awards, Total 455,322.
2024-01-10	Braden R. Kelly. Director since 2013 and Chairman of the Board of Directors since February 2016; Chair of the Governance, Nominating and Executive Committee; Member of the Leadership Development and Compensation Committee; Age 53. ... Mr. Kelly has a deep financial background and contributes a critical business and corporate development perspective to the Board of Directors through his extensive experience with strategic mergers and acquisitions, a key growth opportunity for the Company. ... Director Compensation for Fiscal 2023: Braden R. Kelly total compensation $365,605.
2025-01-27	Braden R. Kelly Chairman of the Board (since 2016) Director (since 2013) Age 54 Independent Committee Assignments Chair Governance, Nominating and Executive Committee Member Leadership Development and Compensation Committee Represents a variety of experiences, qualifications, attributes and skills Compensation Table: FeesEarned orPaid inCash $200,000, OptionAwards $329,929, Total $529,929.